iscador

iscador

Alternative pharmacology
An extract of the European mistletoe, which is believed to stimulate the immune system, increase the white cell count and cause them to engulf and destroy foreign cells, damaged self cells and malignant cells.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
References in periodicals archive ?
In a study conducted by Ding and colleagues (21), the anti-proliferative activity of Fraxini was shown to be almost 10 and 6 times stronger than that of Iscador M and Iscador Q, respectively, in both Hep3B and HepG2 cells.
Delignat et al., "Molecular mechanisms underlying the immunomodulatory effects of mistletoe (Viscum album L.) extracts Iscador," Arzneimittel-Forschung, vol.
Wirral's NHS spends PS16,500 to treat around 50 patients a year using homeopathy and a mistletoe extract known as Iscador.
In addition, one group received Helixor A (HxA), another group received Iscador M, and a control group had no additional therapy.
* Iscador may be considered as an alternative treatment in breast cancer (Ziegler 2008).
The fermented mistletoe medicine is called Iscador.
Viscotoxins, mistletoe lectins and their isoforms in mistletoe (Viscum album L.) extracts Iscador. Arzneimittelforschung, 56(6A):428-434.
Weleda's first and best-selling such medicine is Iscador [R], the mistletoe extract promoted as a complementary cancer treatment that strengthens the immune system, making it easier for the body to support conventional treatments like chemotherapy and radiation.
Francesca says: "Glasgow Homeopathic Hospital gave me a cactus remedy and trained me to inject myself twice weekly with Iscador. It's an extract of mistletoe and is widely used as a cancer treatment in Europe to stimulate the immune system and it's available on the NHS.
In a multicenter, parallel-group, cohort study that included 1,442 patients who initially underwent surgery for early-stage breast cancer, 16% of the 710 patients who received subcutaneous injections of the proprietary formulation Iscador experienced adverse events related to their radiation, chemotherapy or hormone treatment, compared with 54% of the 732 treated with conventional modalities alone, Dr.